Tieton Capital Management Trimmed Myriad Genetics (MYGN) Stake By $4.31 Million; Marathon Partners Equity Management Has Lowered Grubhub (GRUB) Position By $887,500

April 22, 2018 - By Pete Kolinski

Myriad Genetics, Inc. (NASDAQ:MYGN) Logo

Tieton Capital Management Llc decreased Myriad Genetics (MYGN) stake by 50.49% reported in 2017Q4 SEC filing. Tieton Capital Management Llc sold 126,805 shares as Myriad Genetics (MYGN)’s stock declined 14.14%. The Tieton Capital Management Llc holds 124,338 shares with $4.27M value, down from 251,143 last quarter. Myriad Genetics now has $2.02B valuation. The stock decreased 0.48% or $0.14 during the last trading session, reaching $28.9. About 277,808 shares traded. Myriad Genetics, Inc. (NASDAQ:MYGN) has risen 52.68% since April 22, 2017 and is uptrending. It has outperformed by 41.13% the S&P500.

Marathon Partners Equity Management Llc decreased Grubhub Inc (GRUB) stake by 5.95% reported in 2017Q4 SEC filing. Marathon Partners Equity Management Llc sold 12,500 shares as Grubhub Inc (GRUB)’s stock rose 44.05%. The Marathon Partners Equity Management Llc holds 197,500 shares with $14.18 million value, down from 210,000 last quarter. Grubhub Inc now has $8.87B valuation. The stock decreased 0.07% or $0.07 during the last trading session, reaching $101.67. About 816,582 shares traded. GrubHub Inc. (NYSE:GRUB) has risen 206.92% since April 22, 2017 and is uptrending. It has outperformed by 195.37% the S&P500.

Analysts await GrubHub Inc. (NYSE:GRUB) to report earnings on May, 1 before the open. They expect $0.27 EPS, up 12.50% or $0.03 from last year’s $0.24 per share. GRUB’s profit will be $23.54 million for 94.14 P/E if the $0.27 EPS becomes a reality. After $0.31 actual EPS reported by GrubHub Inc. for the previous quarter, Wall Street now forecasts -12.90% negative EPS growth.

Among 33 analysts covering Grubhub Inc (NYSE:GRUB), 17 have Buy rating, 3 Sell and 13 Hold. Therefore 52% are positive. Grubhub Inc had 127 analyst reports since July 27, 2015 according to SRatingsIntel. Canaccord Genuity maintained GrubHub Inc. (NYSE:GRUB) on Friday, February 9 with “Buy” rating. Morgan Stanley upgraded it to “Overweight” rating and $59 target in Monday, August 7 report. Bank of America downgraded the shares of GRUB in report on Friday, July 29 to “Neutral” rating. Barclays Capital maintained it with “Equal-Weight” rating and $56 target in Thursday, October 26 report. Wedbush downgraded the stock to “Neutral” rating in Monday, January 8 report. Cowen & Co downgraded the stock to “Market Perform” rating in Monday, July 27 report. Cowen & Co maintained the shares of GRUB in report on Tuesday, August 15 with “Buy” rating. The rating was initiated by Pacific Crest with “Sector Weight” on Friday, April 8. As per Thursday, December 3, the company rating was initiated by Mizuho. The rating was upgraded by Morgan Stanley on Friday, January 13 to “Overweight”.

Among 20 analysts covering Myriad Genetics (NASDAQ:MYGN), 4 have Buy rating, 4 Sell and 12 Hold. Therefore 20% are positive. Myriad Genetics had 59 analyst reports since July 21, 2015 according to SRatingsIntel. Piper Jaffray maintained the shares of MYGN in report on Tuesday, February 6 with “Hold” rating. The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) has “Neutral” rating given on Tuesday, September 15 by Mizuho. The company was initiated on Tuesday, July 21 by Gabelli. As per Wednesday, August 9, the company rating was maintained by Barclays Capital. Morgan Stanley maintained the shares of MYGN in report on Wednesday, August 10 with “Underweight” rating. UBS maintained Myriad Genetics, Inc. (NASDAQ:MYGN) rating on Wednesday, August 10. UBS has “Sell” rating and $18 target. Morgan Stanley maintained the stock with “Underweight” rating in Wednesday, February 7 report. The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) earned “Equal-Weight” rating by Morgan Stanley on Wednesday, March 21. The firm has “Hold” rating by Jefferies given on Thursday, August 11. The firm has “Hold” rating by Piper Jaffray given on Tuesday, August 8.

Investors sentiment increased to 1.37 in 2017 Q4. Its up 0.51, from 0.86 in 2017Q3. It is positive, as 19 investors sold MYGN shares while 67 reduced holdings. 46 funds opened positions while 72 raised stakes. 71.43 million shares or 0.51% less from 71.79 million shares in 2017Q3 were reported. Contrarius Invest Management Limited owns 235,735 shares. Geode Cap Mgmt Ltd Co stated it has 0.01% in Myriad Genetics, Inc. (NASDAQ:MYGN). Clarivest Asset Mgmt Llc, a California-based fund reported 19 shares. Texas Permanent School Fund has invested 0.02% in Myriad Genetics, Inc. (NASDAQ:MYGN). Millennium Mngmt Llc has 234,476 shares for 0.01% of their portfolio. Bogle Management Ltd Partnership De holds 0.85% or 338,192 shares in its portfolio. Sei Investments Co accumulated 722 shares or 0% of the stock. Quebec – Canada-based Caisse De Depot Et Placement Du Quebec has invested 0.04% in Myriad Genetics, Inc. (NASDAQ:MYGN). Stratos Wealth Partners Limited owns 570 shares or 0% of their US portfolio. Jefferies Gp Ltd Liability Corporation accumulated 9,619 shares. Cornerstone Capital Management Hldgs Ltd Liability Com reported 27,502 shares stake. State Street owns 3.48M shares. Schwab Charles Investment invested 0.02% in Myriad Genetics, Inc. (NASDAQ:MYGN). Moreover, Taylor Frigon Cap Mngmt Limited Liability Corp has 1.22% invested in Myriad Genetics, Inc. (NASDAQ:MYGN). State Board Of Administration Of Florida Retirement Systems holds 0.01% or 95,911 shares.

Myriad Genetics, Inc. (NASDAQ:MYGN) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>